- NPMI

Muscat Securities Market (Sultanat of Oman)
0.12 Last Update 18/09/2018 13:08 KSA
× lblWarning! {{companyMessage}}
  • :0.12
  • :0.12
  • ('000):50,000
  • (OMR '000):6,000
  • :-0.02


  • 0
  • :328
  • :0
  • 52-W L52-W H
    0.12
    0.00000.12
  • -
  • -


  • 0

  • (OMR):

    0
  • (OMR):39
  • :0
  • Performance Comparison

Activities

National Pharmaceutical Industries Company (NPMI) is a public company, based in Muscat (Oman), and established in February 1996. NPMI is a subsidiary of Oman Investment Fund Holding Co. and is listed on the Muscat Securities Market since January 2005. The company specializes in the production of anti-allergic, anti-inflammatory, antidepressant,and anti-diabetic medications, and also gastrointestinal drugs. It is among the first pharmaceutical formulations manufacturing plant in Sultanate of Oman. It offers lipid lowering, cardio vascular, anti-bacterial, anti-allergic, non-steroidal anti-inflammatory, gastro intestinal, anti-diabetic, anti-depressant, and analgesic anti-pyretic products too. The company also operates worldwide in almost 12 countries and has a business base in the Gulf and Middle East counties for almost a decade. The company's facilities are spread over a 30,042.43 square meters plot of land, and includes a non-beta lactum plant for producing oral solids, liquids, drops, dry suspensions and sachets; a beta lactum plant, which engages in production of capsules and dry suspension; a research and development laboratory, and a quality control laboratory.

  • Chairman:
    Ghazi O. Al Zubeidi
  • Vice-chairman:
    Abdullah M. B. Al Qenaei
  • CEO:
    G . Sridhar
  • Board Members:

    Amal S. Bahwan

    Khalifa S. Al Mohannadi

    Mahmoud A. Zubaid

    Omar S. Bahwan

  • Auditors:

    Moore Stephens

CMA clears OMR5m rights issue of National Pharmaceuticals (Times of Oman - 24/12/2017)

National Pharmaceutical Industries Company plans to raise its capital by OMR5 million by way of a ...

Read More ...

Read More ...
Announced On Period As Of Net Profit (SAR Mil) Growth (%)
12/04/2018 3-Month 31/03/2018 00 16.39
14/01/2018 12-Month 31/12/2017 02 21.33
12/10/2017 9-Month 30/09/2017 01 7.05
12/07/2017 6-Month 30/06/2017 01 -9.96
12/04/2017 3-Month 31/03/2017 00 5.06
Market Cap
US$ Mil
Last Price
Local Cry
Price Change (%)
1 Day
Price Change (%)
1 Year
P/E TTM P/B MRQ Dividend Yield (%) Beta ROA (%) ROE (%)
MOUASAT 2,074.48 78.2 0 -2.31 21.1 2.8 1.93 0.72 13.85 22.49
DALLAHHEALTH 1,021.26 64.7 -2.12 -41.49 17.69 2.36 3.85 0.93 12.1 17.53
SPIMACO 969.86 30.55 0.99 -11.16 25.87 1.38 3.29 0.89 8.47 15.11
MEAHCO 911.78 37 0.54 -40.68 13.21 2.1 5.38 0.8 11.92 18.76
JULPHAR 612.34 2.15 7.5 -23.95 28.33 0.97 5.27 0.19 4.09 0
ATC.KSE 543.99 1,100 0 0 18.46 3.34 1.82 -0.01 2.93 12.88
CARE 524.32 44 0.68 5.99 20.48 2.04 2.28 0.88 -0.59 -0.89
MCGS 521.43 66.96 -0.76 -3.34 23.54 1.9 5.93 0.95 6.76 7.99
GMPC 376.68 1.98 0 -1 31.33 1.05 3 -0.08 75.81 111.42
YIACO 76.77 128 0 -26.86 -19.16 2.38 0 0.14 -8.47 -63.6
QGMD 16.08 5.02 -0.99 -34.92 -2.69 0.85 0 0.82 -6.18 0
NPMI 15.56 0.12 0 6.19 3.45 0.76 11.67 -0.02 6.11 0